Date   
FW: Reata plan to submit an MAA to the EMA in the fourth quarter of 2022. --Reata Pharmaceuticals Inc. - Reata Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results and Provides an Update on Clinical Development Programs By Sally Q. Smith ·
Reata Pharmaceuticals Inc. - Reata Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results and Provides an Update on Clinical Development Programs By Sally Q. Smith ·
Friedreich's Ataxia related Diabetes: Epidemiology and management practices - ScienceDirect By Sally Q. Smith ·
FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes By Sally Q. Smith ·
Shawn Logan's Passing 4 messages By Paul Konanz ·
UCF Developing Scam Screener for the Elderly | University of Central Florida News By Sally Q. Smith ·
Career Ideas - Friedreich's Ataxia News Forums 2 messages By Sally Q. Smith ·
Diabetes Question By Paul Konanz ·
FW: [INTERNAF IO] Diabetes Question By Sally Q. Smith ·
Diabetes Question 3 messages By Sally Q. Smith ·
From FARA By Sally Q. Smith ·
FW: Free genetic counseling and testing initiative will expand soon 2 messages By Paul Konanz ·
FDA approves new drug to improve heart function in adults with rare heart condition | FDA 3 messages By Sally Q. Smith ·
FW: [FAPG] FW: Reminder: Accessible living webinar 2 messages By Paul Konanz ·
[FAPG] FW: Reminder: Accessible living webinar By Paul Konanz ·
FW: [FAPG] Office Hours with FARA: Q & A Sessions on the Latest FA Research Headlines By Paul Konanz ·
Lend Us Some Muscle 2022 - Campaign By Sally Q. Smith ·
FW: Reminder: Accessible living webinar 2 messages By Paul Konanz ·
How Older Caregivers Secure the Future for Dependent Adult Children By Sally Q. Smith ·
Finding Zen By Sally Q. Smith ·
1 - 20 of 320